Similar articles for PMID: 26510126

Year	Number of Results
1996	1
2000	1
2004	1
2005	2
2006	1
2007	1
2008	1
2009	1
2010	5
2011	8
2012	6
2013	9
2014	10
2015	11
2016	16
2017	12
2018	10
2019	8
2020	8
2021	1
2022	5
2023	5
2024	0

1

Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.

Scott FI, Mamtani R, Brensinger CM, Haynes K, Chiesa-Fuxench ZC, Zhang J, Chen L, Xie F, Yun H, Osterman MT, Beukelman T, Margolis DJ, Curtis JR, Lewis JD. Scott FI, et al. JAMA Dermatol. 2016 Feb;152(2):164-72. doi: 10.1001/jamadermatol.2015.3029. JAMA Dermatol. 2016. PMID: 26510126 Free PMC article.

2

Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.

Mamtani R, Clark AS, Scott FI, Brensinger CM, Boursi B, Chen L, Xie F, Yun H, Osterman MT, Curtis JR, Lewis JD. Mamtani R, et al. Arthritis Rheumatol. 2016 Oct;68(10):2403-11. doi: 10.1002/art.39738. Arthritis Rheumatol. 2016. PMID: 27159030 Free PMC article.

3

Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.

Long MD, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD. Long MD, et al. Gastroenterology. 2012 Aug;143(2):390-399.e1. doi: 10.1053/j.gastro.2012.05.004. Epub 2012 May 11. Gastroenterology. 2012. PMID: 22584081 Free PMC article.

4

Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.

Chakravarty EF, Michaud K, Wolfe F. Chakravarty EF, et al. J Rheumatol. 2005 Nov;32(11):2130-5. J Rheumatol. 2005. PMID: 16265690

5

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.

Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L; Cesame Study Group. Peyrin-Biroulet L, et al. Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25. Gastroenterology. 2011. PMID: 21708105

6

Risks of Melanoma and Nonmelanoma Skin Cancers Pre- and Post-Inflammatory Bowel Disease Diagnosis.

Narous M, Nugent Z, Singh H, Bernstein CN. Narous M, et al. Inflamm Bowel Dis. 2023 Jul 5;29(7):1047-1056. doi: 10.1093/ibd/izac171. Inflamm Bowel Dis. 2023. PMID: 35929649

7

Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.

Ariyaratnam J, Subramanian V. Ariyaratnam J, et al. Am J Gastroenterol. 2014 Feb;109(2):163-9. doi: 10.1038/ajg.2013.451. Epub 2014 Jan 14. Am J Gastroenterol. 2014. PMID: 24419479 Review.

8

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.

Long MD, Herfarth HH, Pipkin CA, Porter CQ, Sandler RS, Kappelman MD. Long MD, et al. Clin Gastroenterol Hepatol. 2010 Mar;8(3):268-74. doi: 10.1016/j.cgh.2009.11.024. Epub 2010 Jan 16. Clin Gastroenterol Hepatol. 2010. PMID: 20005977 Free PMC article.

9

Nonmelanoma skin cancer in inflammatory bowel disease: a review.

Long MD, Kappelman MD, Pipkin CA. Long MD, et al. Inflamm Bowel Dis. 2011 Jun;17(6):1423-7. doi: 10.1002/ibd.21484. Epub 2010 Nov 4. Inflamm Bowel Dis. 2011. PMID: 21053358 Free PMC article. Review.

10

Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the Literature.

Hagen JW, Pugliano-Mauro MA. Hagen JW, et al. Dermatol Surg. 2018 Apr;44(4):469-480. doi: 10.1097/DSS.0000000000001455. Dermatol Surg. 2018. PMID: 29315147 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year